Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study
| Image |  |
|---|---|
| Description | scientific article published on 10 September 2019 |
| Author/s |
author: Laurent Greillier Charles Rudin |
| Publication date | September 10, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |